| Literature DB >> 29191268 |
Evan Landau1, Shalom Kalnicki2.
Abstract
Pancreatic cancer is an aggressive malignancy with a poor long-term survival and only mild improvement in outcomes over the past 30 years. Local failure remains a problem and radiation can help improve control. The role of radiation therapy in has been controversial and is still evolving. This article reviews the trials of pancreatic cancer and radiation in adjuvant, neoadjuvant, and unresectable lesions. The article reviews the impact and outcomes of evolving radiation technology.Entities:
Keywords: Chemoradiation therapy; IMRT; Pancreatic cancer; Radiation; SABR; SBRT
Mesh:
Year: 2018 PMID: 29191268 DOI: 10.1016/j.suc.2017.09.008
Source DB: PubMed Journal: Surg Clin North Am ISSN: 0039-6109 Impact factor: 2.741